What are the best healthcare stocks for value investors?

KLA Corporation (KLAC) currently leads the healthcare sector on the Benjamin Graham framework with a composite score of 95/100, followed by EW (91/100). The full ranked list of 25 healthcare stocks indexed against the framework is on this page. Educational only, not investment advice.

Which healthcare stock has the highest Buffett-Fit score?

According to invest-like.com, KLA Corporation (KLAC) currently has the highest Buffett-Fit composite score in the healthcare sector at 95/100. invest-like.com's Buffett-Fit Score weighs five pillars (economic moat, earnings durability, management quality, financial health, and valuation) each on a 0-100 sub-scale, and refreshes the cached verdict on a 7-day TTL.

Is healthcare a good sector for Benjamin Graham-style investing?

The healthcare sector's median quality score on invest-like.com is 81/100 with a median ROIC of 13%. Whether healthcare is "good" for Benjamin Graham-style investing depends on which sub-sectors and specific stocks you focus on: the framework's sector-relative scoring means stocks are graded against their own sector benchmarks, not a fixed cross-market hurdle.

Which healthcare stocks have the best moats?

invest-like.com anchors moat strength in the Buffett-Fit framework on ROIC sustainability (above 15% sustained over multiple years) plus gross-margin durability (above 40% in industries where peers sit lower). The healthcare sector's median ROIC on invest-like.com is 13%: the top-scoring stocks on this page are the ones with both quantitative moat anchors clearing the threshold AND qualitative moat sources (brand, switching costs, network effects, regulatory).

How many healthcare stocks does invest-like.com cover?

invest-like.com currently indexes 25 healthcare stocks above $500M market cap with cached verdicts on the Buffett-Fit framework. invest-like.com scores each stock from 0 to 100, with sub-scores for moat, durability, management, financial health, and valuation. The full ranked list is on this page.

Is the healthcare ranking on this page investment advice?

No. invest-like.com publishes the ranking as an educational pattern-match against documented value-investing frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith). invest-like.com's scores reflect how closely each stock fits the documented criteria: they are NOT recommendations to buy, hold, or sell. Always do your own research and consult a licensed financial adviser for personalised investment advice.

Healthcare · Benjamin Graham fit

Best Healthcare Stocks for Benjamin Graham Investors

Top 25 healthcare stocks ranked by their Benjamin Graham fit score, every score computed from current financials against published criteria. Updated daily.

How We Rank These

Each stock is scored on a 0–100 scale across the Benjamin Graham criteria (moat, durability, valuation, financial health, capital allocation). The score is a deterministic function of the company's TTM financials, no opinion, no hand-tuning. Rows with insufficient data are excluded.

The Top 25

#1
95/100
KLACKLA Corporation95/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$218.5B
ROIC
38.16%
#2
91/100
EWEdwards Lifesciences Corporation91/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$54.38B
ROIC
12.06%
#3
90/100
HALOHalozyme Therapeutics, Inc.90/100
Meets 3/7 Graham criteria, classic deep-value candidate.
Mkt cap
$14.89B
ROIC
23.65%
#4
90/100
LLYEli Lilly and Company90/100
Meets 2/7 Graham criteria, classic deep-value candidate.
Mkt cap
$1.22T
ROIC
34.84%
#5
89/100
IRMDIRadimed Corporation89/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$1.1B
ROIC
21.38%
#6
89/100
ISRGIntuitive Surgical, Inc.89/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$158.54B
ROIC
13.39%
#7
88/100
WSTWest Pharmaceutical Services, Inc.88/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$29.32B
ROIC
15.24%
#8
85/100
LMATLeMaitre Vascular, Inc.85/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$1.95B
ROIC
9.43%
#9
84/100
AMGNAmgen Inc.84/100
Meets 2/7 Graham criteria, classic deep-value candidate.
Mkt cap
$249.09B
ROIC
15.02%
#10
84/100
CORTCorcept Therapeutics Incorporated84/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$9.29B
ROIC
-1.23%
#11
82/100
RPRXRoyalty Pharma plc82/100
Meets 3/7 Graham criteria, classic deep-value candidate.
Mkt cap
$38.1B
ROIC
8.43%
#12
81/100
PODDInsulet Corporation81/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$10.58B
ROIC
16.39%
#13
81/100
TECHBio-Techne Corporation81/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$11.4B
ROIC
4.75%
#14
81/100
IDXXIDEXX Laboratories, Inc.81/100
Meets 3/7 Graham criteria, classic deep-value candidate.
Mkt cap
$45.44B
ROIC
40.66%
#15
80/100
SHCSotera Health Company80/100
Meets 2/7 Graham criteria, classic deep-value candidate.
Mkt cap
$5.34B
ROIC
7.96%
#16
79/100
XERSXeris Biopharma Holdings, Inc.79/100
Meets 2/7 Graham criteria, classic deep-value candidate.
Mkt cap
$1.96B
ROIC
12.84%
#17
79/100
MSAMSA Safety Incorporated79/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$6.91B
ROIC
14.03%
#18
78/100
CDRECadre Holdings, Inc.78/100
Meets 3/7 Graham criteria, classic deep-value candidate.
Mkt cap
$1.33B
ROIC
7.38%
#19
77/100
HAEHaemonetics Corporation77/100
Meets 3/7 Graham criteria, classic deep-value candidate.
Mkt cap
$5.45B
ROIC
8.37%
#20
77/100
SYKStryker Corporation77/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$119.58B
ROIC
9.79%
#21
76/100
NBIXNeurocrine Biosciences, Inc.76/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$14.88B
ROIC
13.68%
#22
76/100
PNTGThe Pennant Group, Inc.76/100
Meets 2/7 Graham criteria, classic deep-value candidate.
Mkt cap
$1.48B
ROIC
4.96%
#23
76/100
ALNYAlnylam Pharmaceuticals, Inc.76/100
Meets 2/7 Graham criteria, classic deep-value candidate.
Mkt cap
$23.28B
ROIC
19.66%
#24
76/100
PAHCPhibro Animal Health Corporation76/100
Meets 3/7 Graham criteria, classic deep-value candidate.
Mkt cap
$1.58B
ROIC
11.17%
#25
76/100
UTHRUnited Therapeutics Corporation76/100
Meets 4/7 Graham criteria, classic deep-value candidate.
Mkt cap
$25.46B
ROIC
18.81%

Same Sector, Other Strategies

Best Healthcare for Warren Buffett Best Healthcare for Peter Lynch Best Healthcare for Joel Greenblatt